cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis

Journal of Virology

Volumn 80, Issue 4, 2006, Pages 2045-2050

  Yue, Wei ^a   Shackelford, Julia ^a   Pagano, Joseph S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 2; LATENT MEMBRANE PROTEIN 1; SERINE; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; ENZYME ACTIVE SITE; EPSTEIN BARR VIRUS; FOLLOW UP; LATENT VIRUS INFECTION; MITOSIS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS GENE;

AMINO ACID SUBSTITUTION; CDC2 PROTEIN KINASE; CYCLIN B; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; MITOSIS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHOSPHORYLATION; RNA, MESSENGER; RNA, VIRAL; SEQUENCE ALIGNMENT; SERINE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 32444441332     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.4.2045-2050.2006     Document Type: Article

References (49)

1. Abbot, S. D., M. Rowe, K. Cadwallader, A. Ricksten, J. Gordon, F. Wang, L. Rymo, and A. B. Rickinson. 1990. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J. Virol. 64:2126-2134.
2. Alberts, B. B. D., J. Lewis, M. Raff, K. Roberts, and J. D. Watson. 1989. Cell growth and division, p.729-790. In R. Adams and A. Walker (ed.), Molecular biology of the cell. Garland Publishing, Inc., New York, N.Y.
3. Aviel, S., G. Winberg, M. Massucci, and A. Ciechanover. 2000. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway: targeting via ubiquitination of the N-terminal residue. J. Biol. Chem. 275:23491-23499.
4. Baichwal, V. R., and B. Sugden. 1987. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J. Virol. 63:866-875.
5. Bonnet, M., J. M. Guinebretiere, E. Kremmer, V. Grunewald, E. Benhamou, G. Contesso, and I. Joab. 1999. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91:1376-1381.
6. 1-S border. Exp. Cell Res. 68:163-168.
7. Calos, M. P. 1998. Stability without a centromere. Proc. Natl. Acad. Sci. USA 95:4084-4085.
8. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
9. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81:7632-7636.
10. Dambaugh, T., F. Wang, K. Hennessy, E. Woodland, A. Rickinson, and E. Kieff. 1986. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells. J. Virol. 59:453-462.
11. Davenport, M. G., and J. S. Pagano. 1999. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J. Virol. 73:3154-3161.
12. Dyson, P. J., and P. J. Farrell. 1985. Chromatin structure of Epstein-Barr virus. J. Gen. Virol. 66:1931-1940.
13. Gottesfeld, J. M., and D. J. Forbes. 1997. Mitotic repression of the transcriptional machinery. Trends Biochem. Sci. 22:197-202.
14. Grasser, F. A., P. Haiss, and N. Mueller-Lantzsch. 1991. Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J. Virol. 65:3779-3788.
15. Grinstein, S., M. V. Preciado, P. Gattuso, P. A. Chabay, W. H. Warren, E. De Matteo, and V. E. Gould. 2002. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 62:4876-4878.
16. Harada, S., and E. Kieff. 1997. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J. Virol. 71:6611-6618.
17. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jk. Science 265:92-95.
18. Hennessy, K., and E. Kieff. 1983. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc. Natl. Acad. Sci. USA 80:5665-5669.
19. Jackman, J., and P. M. O'Commor. 1998. Cell cycle analysis, p. 8.0.1-8.0.13. In J. S. Bonifacino, M. Dasso, J. B. Harford, J. Lippincott-Schwartz, and K. M. Yamada (ed.), Current protocols in cell biology, vol. 1. John Wiley & Sons, Inc., New York, N.Y.
20. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by Jκ and PU. 1. J. Virol. 69:253-262.
21. Kelly, G., A. Bell, and A. Rickinson. 2002. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8:1098-1104.
22. Kwiatkowski, B., S. Y. J. Chen, and W. H. Schubach. 2004. CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation. J. Virol. 78:6067-6072.
23. Lee, J.-S., K. M. Collins, A. L. Brown, C.-H. Lee, and J. H. Chung. 2000. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404:201-204.
24. Lee, S. Y., M. R. Wenk, Y. Kim, A. C. Nairn, and P. De Camilli. 2004. Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc. Natl. Acad. Sci. USA 101:546-551.
25. Leibold, W., T. D. Flanagan, J. Menezes, and G. Klein. 1975. Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells. J. Natl. Cancer Inst. 54:65-68.
26. Lindahl, T., A. Adams, G. Bjursell, G. W. Bornkamm, C. Kaschka-Dierich, and U. Jehn. 1976. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J. Mol. Biol. 102:511-530.
27. Ling, P. D., and S. D. Hayward. 1995. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J. Virol. 69:1944-1950.
28. Ling, P. D., J. J. Ryon, and S. D. Hayward. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:2990-3003.
29. Moreno, S., and P. Nurse. 1990. Substrates for p34 cdc2: in vivo veritas? Cell 61:549-551.
30. Ning, S., A. M. Hahn, L. E. Huye, and J. S. Pagano. 2003. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J. Virol. 77:9359-9368.
31. Obenauer, J. C., L. C. Cantley, and M. B. Yaffe. 2003. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31:3635-3641.
32. Peng, R., A. V. Gordadze, E. M. Fuentes Panana, F. Wang, J. Zong, G. S. Hayward, J. Tan, and P. D. Ling. 2000. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J. Virol. 74:379-389.
33. Pope, J. H. 1967. Establishment of cell lines from peripheral leucocytes in infectious mononucleosis. Nature 216:810-811.
34. Prescott, D. M., and M. A. Bender. 1962. Synthesis of RNA and protein during mitosis in mammalian tissue culture cells. Exp. Cell Res. 26:260-268.
35. Rayet, B., Y. Fan, and C. Gelinas. 2003. Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-κB-regulated cell death inhibitors important for v-Rel transforming activity. Mol. Cell. Biol. 23:1520-1533.
36. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott, Philadelphia, Pa.
37. Sexton, C. J., and J. S. Pagano. 1989. Analysis of the Epstein-Barr virus origin of plasmid replication (oriP) reveals an area of nucleosome sparing that spans the 3′ dyad. J. Virol. 63:5505-5508.
38. Shaw, J. E., L. F. Levinger, and C. W., Jr. Carter. 1979. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J. Virol. 29:657-665.
39. Speck, S. H., and J. L. Strominger. 1989. Transcription of Epstein-Barr virus in latently infected growth-transformed lymphocytes. Adv. Viral. Oncol. 8:133-150.
40. Sung, N. S., S. Kenney, D. Gutsch, and J. S. Pagano. 1991. EBNA-2 transactivates a lymphoid-specific enhancer in the Bam H1 C promoter of Epstein-Barr virus. J. Virol. 65:2164-2169.
41. Taylor, J. H. 1960. Nucleic acid synthesis in relation to the cell division cycle. Ann. N. Y. Acad. Sci. 90:409-421.
42. Terasima, T., and L. J. Tolmach. 1963. Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells. Exp. Cell Res. 30:344-362.
43. Wang, F., S. F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff. 1990. Epstein-Bar virus nuclear antigen 2 transactivates latent membrane protein LMP-1. J. Virol. 64:3407-3416.
44. Woisetschlaeger, M., J. L. Strominger, and S. H. Speck. 1989. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 86:6498-6502.
45. Woisetschlaeger, M., C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87:1725-1729.
46. Yue, W., M. G. Davenport, J. Shackelford, and J. S. Pagano. 2004. Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function. J. Virol. 78:3542-3552.
47. Yue, W., E. Gershburg, and J. S. Pagano. 2005. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. J. Virol. 79:5880-5885.
48. Zimber-Strobl, U., E. Kremmer, F. Grasser, G. Marschall, G. Laux, and G. W. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA-2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12:167-175.
49. Zimber-Strobl, U., K. O. Suentzenich, G. Laux, D. Eick, M. Cordier, A. Calender, M. Billaud, G. M. Lenoir, and G. W. Bornkamm. 1991. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65:415-423.